MidCap Equity Insight

Bath & Body Works: Q3 results top guidance, but sales and EPS decline year over year

Bath & Body Works: Q3 results top guidance, but sales and EPS decline year over year

Q3 2026 sales and adjusted EPS exceeded company guidance, but both declined year over year. Bath & Body Works raised its full-year sales outlook and authorized a new $500 million share repurchase; holiday-season demand is the next test.

Sources (2)
Updated Nov 19, 2026
Bath & Body Works: Q3 results top guidance, but sales and EPS decline year over year - MidCap Equity Insight | NBot | nbot.ai